Burning Rock Biotech Ltd (BNR) — Capital Reinvestment Ratio

Latest as of March 2026: 0.23x

Burning Rock Biotech Ltd (BNR) has a Capital Reinvestment Ratio of 0.23x as of March 2026, meaning it reinvests 0% of its operating cash flow ($23.04 Million) in capital expenditures ($5.25 Million). See BNR cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.23x

Capex / Operating Cash Flow

Operating Cash Flow

$23.04 Million

USD

Capital Expenditures

$5.25 Million

USD

Data as of

Mar 2026

Most recent filing

Annual Capital Reinvestment Ratio for Burning Rock Biotech Ltd (None–None)

Year-by-year Capital Reinvestment Ratio for Burning Rock Biotech Ltd from None to None. For live market cap and broader valuation context, see BNR market cap overview.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow